← Leaderboards
Sandro Matosevic
Purdue University
$383,645
Attributed
$383,645
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $207.8K · FY2021–22$250K$187.5K$125K$62.5K$0
'21
'22
Funding mix
By agency
NIH$383,645 · 1
By mechanism
R21$383,645 · 1
Top collaborators
No co-investigators on record.
Most similar at Purdue University
Same institution · by research overlap
- Guang Yang$10,418,153
- Xiaoping Bao$1,599,560
- Jason C Porta$169,294
- Chongli Yuan$4,049,519
- Ranjie Xu$1,208,898
Others in their field
Other Emerging Leaders on “Adenosine”
- Danielle L Swaney · University Of California, San Francisco$4,769,065
- Theodore E Liston · Astrocyte Pharmaceuticals, Inc.$4,495,704
- Wei Lu · Van Andel Research Institute$4,058,147
- Bing Yao · Emory University$3,941,624
- Kim-Lien T Nguyen · Va Greater Los Angeles Healthcare System$3,836,883
- Rebecca Diane Levit · Emory University$3,716,694
Research focus
AdenosineAdoptive Cell TransfersAdoptive TransferAllogenicAnaerobic GlycolysisAntibodiesAntitumor ResponseArchitectureBaseBindingBlood - Brain Barrier AnatomyBrain NeoplasmsCaringCellsChemokineChimeric Antigen ReceptorClinical TranslationClinical TreatmentCytokineCytolysisCytotoxicityDiagnosisEffector CellAblation
Grant awards (2)
Usurping TIGIT and CD73 activities with responsive, genetically-engineered NK cells as immunotherapy for glioblastoma$207,796
R21 · FY2022 · CA · contact PI
Usurping TIGIT and CD73 activities with responsive, genetically-engineered NK cells as immunotherapy for glioblastoma$175,849
R21 · FY2021 · CA · contact PI